Ken Griffin's position in Nuvation Bio is currently worth $4.57 Million. That's 0.00% of their equity portfolio (1646th largest holding). The first Nuvation Bio trade was made in Q1 2021. Since then Ken Griffin bought shares five more times and sold shares on ten occasions. The investor's estimated purchase price is $21.1 Million, resulting in a loss of 78%.